Maria Fernanda C. Leal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Fernanda C. Leal has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Rita I. L. Catarino
FCS-UFP—Health Sciences Faculty, University Fernando Pessoa, 4249-004 Porto, Portugal
10 shared publications - Adriana M. Pimenta
FCS-UFP—Health Sciences Faculty, University Fernando Pessoa, 4249-004 Porto, Portugal
7 shared publications - Maria Renata S. Souto
FCS-UFP—Health Sciences Faculty, University Fernando Pessoa, 4249-004 Porto, Portugal
6 shared publications - Inês Lopes Cardoso
RISE-Health, Faculty of Health Sciences, Fernando Pessoa University, Fernando Pessoa Teaching and Culture Foundation, 4249-004 Porto, Portugal
4 shared publications M.Teresa S.D Vasconcelos
Chemistry Department, Faculty of Science, University of Porto, Rua do Campo Alegre 687, 4169-007 Oporto, Portugal
4 shared publicationsAdriana M. Pimenta
3 shared publications
Latest Publications
- 19 September 2026
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 30 (10) , 453
Cystic fibrosis and its impact on the oral cavity and dental treatments – a scoping review
Objectives Cystic fibrosis is an autosomal recessive disease caused by mutations in the CFTR gene, mainly affecting the respiratory and digestive systems. Advances in diagnosis and treatment have increased life expectancy, making cystic fibrosis a chronic condition requiring long-term multidisciplinary care. Consequently, oral health has gained importance, as disease manifestations and prolonged therapies may influence the oral cavity and dental management. This review aimed to analyse the available scientific evidence regarding the impact of cystic fibrosis on oral health and dental treatments. The guiding research question was: What is the impact of cystic fibrosis on the oral cavity and dental treatments? Methodology A literature search was conducted in PubMed, Scopus, Web of Science and Cochrane Library using the keywords: cystic fibrosis, oral health, and dental treatment. After applying inclusion and exclusion criteria, 22 articles were selected. Results Although findings remain heterogeneous, the included studies suggest that cystic fibrosis is associated with specific oral changes. In children, a lower prevalence of dental caries was frequently reported, often linked to prolonged antibiotic use. In adults, studies indicated a higher prevalence of untreated caries and poorer oral health status. Developmental enamel defects and salivary alterations were also commonly observed. Conclusions Cystic fibrosis may significantly affect oral health, highlighting the need for individualized dental care focused on prevention, regular monitoring, and adaptation to each patient’s specific needs. Clinical Relevance Individualized preventive and therapeutic strategies, regular monitoring, and integration of dental professionals into multidisciplinary teams may improve oral health outcomes, treatment adherence, and quality of life.
- 19 September 2026
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 30 (10) , 453
Cystic fibrosis and its impact on the oral cavity and dental treatments – a scoping review
Objectives Cystic fibrosis is an autosomal recessive disease caused by mutations in the CFTR gene, mainly affecting the respiratory and digestive systems. Advances in diagnosis and treatment have increased life expectancy, making cystic fibrosis a chronic condition requiring long-term multidisciplinary care. Consequently, oral health has gained importance, as disease manifestations and prolonged therapies may influence the oral cavity and dental management. This review aimed to analyse the available scientific evidence regarding the impact of cystic fibrosis on oral health and dental treatments. The guiding research question was: What is the impact of cystic fibrosis on the oral cavity and dental treatments? Methodology A literature search was conducted in PubMed, Scopus, Web of Science and Cochrane Library using the keywords: cystic fibrosis, oral health, and dental treatment. After applying inclusion and exclusion criteria, 22 articles were selected. Results Although findings remain heterogeneous, the included studies suggest that cystic fibrosis is associated with specific oral changes. In children, a lower prevalence of dental caries was frequently reported, often linked to prolonged antibiotic use. In adults, studies indicated a higher prevalence of untreated caries and poorer oral health status. Developmental enamel defects and salivary alterations were also commonly observed. Conclusions Cystic fibrosis may significantly affect oral health, highlighting the need for individualized dental care focused on prevention, regular monitoring, and adaptation to each patient’s specific needs. Clinical Relevance Individualized preventive and therapeutic strategies, regular monitoring, and integration of dental professionals into multidisciplinary teams may improve oral health outcomes, treatment adherence, and quality of life.
- Open Access
- 20 July 2026
- Published by Springer Nature in BioMetals
- Vol. 39 (5) , 1385-1398
The role of metals in cancer and the use of metal chelators as a potential treatment strategy
Biometals such as iron, copper, zinc, manganese, cobalt, and selenium play crucial roles in cellular respiration, immunity, apoptosis, and signaling. However, their excessive accumulation can induce chronic inflammation, oxidative stress, and trigger carcinogenesis. Iron addiction stands out for its importance in tumor cell replication and survival. Cancer remains one of the leading causes of mortality worldwide. Given the limitations of conventional therapies, new approaches have been explored, namely the use of metal chelators, with the aim of selectively modulating metal homeostasis in tumor cells. Metal chelation represents a promising therapeutic approach in the treatment of cancer. Metal chelators such as DFO and DFX demonstrate antineoplastic activity, although limited by low selectivity and systemic toxicity. Thiosemicarbazones, particularly Triapine, have demonstrated anticancer and antimetastatic activity in preclinical models, with clinical trials currently underway to treat tumors. SK4 appears to be a promising alternative, with greater selectivity for tumor cells, inducing apoptosis, demonstrating superior efficacy and lower toxicity. Its efficacy in preclinical models and selective profile support the need for clinical validation, potentially integrating more targeted, safe, and effective oncological therapy. Thus, the aim of this manuscript is to analyze the role of metals in cancer and evaluate the therapeutic potential of metal chelators.
- 20 July 2026
- Published by Springer Nature in BioMetals
- Vol. 39 (5) , 1385-1398
Open AccessThe role of metals in cancer and the use of metal chelators as a potential treatment strategy
Biometals such as iron, copper, zinc, manganese, cobalt, and selenium play crucial roles in cellular respiration, immunity, apoptosis, and signaling. However, their excessive accumulation can induce chronic inflammation, oxidative stress, and trigger carcinogenesis. Iron addiction stands out for its importance in tumor cell replication and survival. Cancer remains one of the leading causes of mortality worldwide. Given the limitations of conventional therapies, new approaches have been explored, namely the use of metal chelators, with the aim of selectively modulating metal homeostasis in tumor cells. Metal chelation represents a promising therapeutic approach in the treatment of cancer. Metal chelators such as DFO and DFX demonstrate antineoplastic activity, although limited by low selectivity and systemic toxicity. Thiosemicarbazones, particularly Triapine, have demonstrated anticancer and antimetastatic activity in preclinical models, with clinical trials currently underway to treat tumors. SK4 appears to be a promising alternative, with greater selectivity for tumor cells, inducing apoptosis, demonstrating superior efficacy and lower toxicity. Its efficacy in preclinical models and selective profile support the need for clinical validation, potentially integrating more targeted, safe, and effective oncological therapy. Thus, the aim of this manuscript is to analyze the role of metals in cancer and evaluate the therapeutic potential of metal chelators.
- Open Access
- 8 April 2026
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 94 (2) , 29
Three Decades of Taxanes: Exploring the Next Frontier
Taxanes, such as paclitaxel and docetaxel, are microtubule-stabilizing agents widely used in oncology, either as monotherapy or in combination regimens. While highly effective, these first-generation taxanes face important limitations, including significant toxicity, reduced water solubility, and the emergence of multidrug resistance. To address these challenges, semi-synthetic taxoids have been developed, aiming to improve pharmacological profiles and overcome therapeutic barriers. Central to these efforts is the understanding of structure-activity relationships, which guides the rational design of taxane analogues with enhanced efficacy and safety. This review explores recent advances in taxoid development, highlights findings from clinical trials, and evaluates how these new agents compare with traditional taxanes in terms of therapeutic potential and tolerability. While novel delivery systems offer improved outcomes with existing drugs, the development of new taxane analogues remains a promising approach to address drug resistance, albeit with challenges related to toxicity, high costs, and historically low success rates in drug development. Furthermore, taxanes are already used in certain cardiovascular conditions and show emerging potential in neurodegenerative diseases, although current evidence remains largely limited to preclinical or early-phase clinical studies. These developments mark an important evolution in the field and offer new opportunities for future therapeutic strategies.
- 8 April 2026
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 94 (2) , 29
Open AccessThree Decades of Taxanes: Exploring the Next Frontier
Taxanes, such as paclitaxel and docetaxel, are microtubule-stabilizing agents widely used in oncology, either as monotherapy or in combination regimens. While highly effective, these first-generation taxanes face important limitations, including significant toxicity, reduced water solubility, and the emergence of multidrug resistance. To address these challenges, semi-synthetic taxoids have been developed, aiming to improve pharmacological profiles and overcome therapeutic barriers. Central to these efforts is the understanding of structure-activity relationships, which guides the rational design of taxane analogues with enhanced efficacy and safety. This review explores recent advances in taxoid development, highlights findings from clinical trials, and evaluates how these new agents compare with traditional taxanes in terms of therapeutic potential and tolerability. While novel delivery systems offer improved outcomes with existing drugs, the development of new taxane analogues remains a promising approach to address drug resistance, albeit with challenges related to toxicity, high costs, and historically low success rates in drug development. Furthermore, taxanes are already used in certain cardiovascular conditions and show emerging potential in neurodegenerative diseases, although current evidence remains largely limited to preclinical or early-phase clinical studies. These developments mark an important evolution in the field and offer new opportunities for future therapeutic strategies.
- Open Access
The Impact of Genetics on Craniofacial Dysplasias and Consequent Oral Malformations—Integrative Review
Background/Objectives: Diseases affecting the craniofacial skeleton are normally associated with disturbances in the regulation of cellular differentiation, the development of bone structures, and changes in bone density and ossification. Thus, the objective of this integrative review is to evaluate the published scientific literature from the last 8 years concerning the impact of genetics on some craniofacial dysplasias. Our aim covers the identification of oral cavity alterations to those dysplasias, through the most common orofacial manifestations. Three dysplasias were selected to be part of this integrative review: cleidocranial dysplasia, ectodermal dysplasia and Apert syndrome. Methods: For this purpose, a bibliographic search was performed in the PubMed, ScienceDirect, Web of Science and Google Scholar databases with several keywords combined with each other. The research question of this review was as follows: “What is the impact of genetic factors on the development of craniofacial dysplasias and associated oral malformations?”. Results: After selecting the articles through the application of inclusion and exclusion criteria, 11 articles were selected for this review. Conclusions: Genetics plays a crucial role in craniofacial dysplasias and subsequent oral malformations. The main conclusion was that mutations in different genes can lead to identical phenotypes, while mutations in the same gene can present slight phenotypic differences depending on where they occur. In the future, it would be important to conduct studies with larger samples and control groups that include genetic testing to allow for a more comprehensive study on the impact of genetics on craniofacial dysplasias.
Open AccessThe Impact of Genetics on Craniofacial Dysplasias and Consequent Oral Malformations—Integrative Review
Background/Objectives: Diseases affecting the craniofacial skeleton are normally associated with disturbances in the regulation of cellular differentiation, the development of bone structures, and changes in bone density and ossification. Thus, the objective of this integrative review is to evaluate the published scientific literature from the last 8 years concerning the impact of genetics on some craniofacial dysplasias. Our aim covers the identification of oral cavity alterations to those dysplasias, through the most common orofacial manifestations. Three dysplasias were selected to be part of this integrative review: cleidocranial dysplasia, ectodermal dysplasia and Apert syndrome. Methods: For this purpose, a bibliographic search was performed in the PubMed, ScienceDirect, Web of Science and Google Scholar databases with several keywords combined with each other. The research question of this review was as follows: “What is the impact of genetic factors on the development of craniofacial dysplasias and associated oral malformations?”. Results: After selecting the articles through the application of inclusion and exclusion criteria, 11 articles were selected for this review. Conclusions: Genetics plays a crucial role in craniofacial dysplasias and subsequent oral malformations. The main conclusion was that mutations in different genes can lead to identical phenotypes, while mutations in the same gene can present slight phenotypic differences depending on where they occur. In the future, it would be important to conduct studies with larger samples and control groups that include genetic testing to allow for a more comprehensive study on the impact of genetics on craniofacial dysplasias.
- Open Access
- 10 September 2025
- Published by MDPI AG in Pollutants
- Vol. 5 (3) , 29
Heavy Metals in Milk and Dairy Products: Safety and Analysis
Milk and dairy products play a key role in the human diet but may also be vehicles for toxic contaminants, particularly heavy metals and metalloids (HMs), such as lead (Pb), cadmium (Cd), mercury (Hg), and arsenic (As). This integrative review examines peer-reviewed studies published between 2015 and 2025 to examine sources, occurrence, and health risks associated with HM contamination in milk and dairy products. Key sources include industrial emissions, agricultural runoff, contaminated feed and water, and inadequate packaging. This review highlights regulatory inconsistencies, limited surveillance, and underuse of metal speciation analysis, which hinder accurate toxicity assessment. Advances in trace-level HM detection systems are discussed in terms of sensitivity, accessibility, and feasibility. Studies from diverse geographic regions frequently report high levels of Pb and Cd in samples originating from industrialized areas in low- and middle-income countries. Health risk indicators, such as target hazard quotients (THQs) and margins of exposure (MOEs), often exceed safety thresholds, particularly in children, indicating significant public health risks, especially with prolonged exposure. These findings underscore the urgent need for systematic contaminant monitoring, harmonized regulations, source-focused mitigation policies, and investment in rapid, cost-effective testing technologies to safeguard milk and dairy product safety worldwide.
- 10 September 2025
- Published by MDPI AG in Pollutants
- Vol. 5 (3) , 29
Open AccessHeavy Metals in Milk and Dairy Products: Safety and Analysis
Milk and dairy products play a key role in the human diet but may also be vehicles for toxic contaminants, particularly heavy metals and metalloids (HMs), such as lead (Pb), cadmium (Cd), mercury (Hg), and arsenic (As). This integrative review examines peer-reviewed studies published between 2015 and 2025 to examine sources, occurrence, and health risks associated with HM contamination in milk and dairy products. Key sources include industrial emissions, agricultural runoff, contaminated feed and water, and inadequate packaging. This review highlights regulatory inconsistencies, limited surveillance, and underuse of metal speciation analysis, which hinder accurate toxicity assessment. Advances in trace-level HM detection systems are discussed in terms of sensitivity, accessibility, and feasibility. Studies from diverse geographic regions frequently report high levels of Pb and Cd in samples originating from industrialized areas in low- and middle-income countries. Health risk indicators, such as target hazard quotients (THQs) and margins of exposure (MOEs), often exceed safety thresholds, particularly in children, indicating significant public health risks, especially with prolonged exposure. These findings underscore the urgent need for systematic contaminant monitoring, harmonized regulations, source-focused mitigation policies, and investment in rapid, cost-effective testing technologies to safeguard milk and dairy product safety worldwide.
- 1 July 2023
- Published by Dustri-Verlag Dr. Karl Feistle in Trace Elements and Electrolytes
- Vol. 40 (07) , 126-138
Metal chelators as part of a strategy for the treatment of neurodegenerative diseases
- 1 July 2023
- Published by Dustri-Verlag Dr. Karl Feistle in Trace Elements and Electrolytes
- Vol. 40 (07) , 126-138
Metal chelators as part of a strategy for the treatment of neurodegenerative diseases
- 1 January 2023
- Published by Springer Nature in Neurophysiology
- Vol. 55 (1-2) , 8-30
Bioactive compounds from marine macroalgae in the treatment and prevention of neurodegenerative diseases
- 1 January 2023
- Published by Springer Nature in Neurophysiology
- Vol. 55 (1-2) , 8-30
Bioactive compounds from marine macroalgae in the treatment and prevention of neurodegenerative diseases
- 1 January 2023
- Published by Dustri-Verlag Dr. Karl Feistle in Trace Elements and Electrolytes
- Vol. 40 (01) , 1-22
The influence of the biometals Cu, Fe, and Zn and the toxic metals Cd and Pb on human health and disease
- 1 January 2023
- Published by Dustri-Verlag Dr. Karl Feistle in Trace Elements and Electrolytes
- Vol. 40 (01) , 1-22
The influence of the biometals Cu, Fe, and Zn and the toxic metals Cd and Pb on human health and disease
- 18 December 2020
- Published by Springer Nature
- p. 35-57
C-Reactive Protein and Neurodegenerative Diseases
- 18 December 2020
- Published by Springer Nature
- p. 35-57
C-Reactive Protein and Neurodegenerative Diseases
- Open Access
- 1 September 2020
- Published by Innovative Journal in Journal of Medical Care Research and Review
- Vol. 3 (9) , 444-453
Systemic Lupus Erythematosus and implications for the oral cavity
Systemic Lupus Erythematosus affects several people around the world and because it is characterized as a chronic inflammatory disease of multifactorial origin, and with systemic impairment, great attention must be paid from diagnosis to treatment in order to optimize the entire follow-up of the patient. The dental doctor plays an important role in the diagnosis of the condition and must be attentive to the early signs that can appear in the oral cavity with a frequency of up to 21%. In this way, through this bibliographic review, which has as main goal to correlate Systemic Lupus Erythematosus with its direct consequences in the oral cavity, it will be possible to help dentists in the diagnosis, to understand in detail the development of the disease and what attitude should be taken in its presence.
- 1 September 2020
- Published by Innovative Journal in Journal of Medical Care Research and Review
- Vol. 3 (9) , 444-453
Open AccessSystemic Lupus Erythematosus and implications for the oral cavity
Systemic Lupus Erythematosus affects several people around the world and because it is characterized as a chronic inflammatory disease of multifactorial origin, and with systemic impairment, great attention must be paid from diagnosis to treatment in order to optimize the entire follow-up of the patient. The dental doctor plays an important role in the diagnosis of the condition and must be attentive to the early signs that can appear in the oral cavity with a frequency of up to 21%. In this way, through this bibliographic review, which has as main goal to correlate Systemic Lupus Erythematosus with its direct consequences in the oral cavity, it will be possible to help dentists in the diagnosis, to understand in detail the development of the disease and what attitude should be taken in its presence.